Free Shipping on All Orders $75 Or More!

Your Trusted Brand for Over 35 Years

Life Extension Magazine

<< Back to April 2012

Lethal Shortages

April 2012

By William Faloon

Not Enough Members Are Buying Pharmocracy

Not Enough Members Are Buying Pharmocracy

Life Extension expended enormous time and money getting this book out to as many decision makers and concerned citizens as possible. One of our members even donated national airtime for multiple 30-minute airings of an interview I did that explained how important it is for citizens to revolt against a medical establishment that is bankrupting the United States.

We have only sold about 7,000 copies of Pharmocracy so far. This is disappointing because my purpose of writing this hardcover book was to enable members to purchase four copies for only $8 each and send one with a personalized letter to their representative and two senators.

The only reason I can think that more of our 170,000 members have not purchased four copies of Pharmocracy is they feared Congress would not pay attention to the irrefutable logic about how to mend today’s broken health care system.

Since 86% of Americans disapprove of how Congress is doing their job, I can understand the apathy of thinking anything can be done to make our government see logic. But that is no reason to surrender. When the free market reforms advocated in Pharmocracy are enacted, it is my firm belief that cures for most of today’s killer diseases will be rapidly brought to market at affordable prices.

I state “when” these reforms are enacted because one way or another, the free market approaches I espouse will emerge, since it is mathematically impossible for the federal government to pay for Medicare, Medicaid, and other health care programs it is currently on the hook for.

One unsettling scenario is that seniors may retain their Medicare benefits (with much higher co-pays), but few doctors will be willing to accept it because Medicare reimbursements will be substantially cut, or payments to doctors delayed.

Don’t Capitulate to Bureaucrats

Don’t Capitulate to Bureaucrats

When the FDA tried to destroy our organization in the late 1980s, almost every attorney we consulted with told us to shut down the Life Extension Foundation. These FDA-expert attorneys said according to the law, we were not allowed to exist. My immediate response was that we had to “change the law.” I was universally ridiculed for suggesting that our small organization had the ability to amend federal law.

On October 15, 1994, a multi-year effort to “change the law” prevailed when the United States Congress passed the Dietary Supplement Health and Education Act (DSHEA).

Pharmocracy by itself may not result in the law being changed, but it provides common sense logic to do so. The more copies of Pharmocracy that members send to their members of Congress, the closer we come to achieving liberation from the FDA’s stranglehold on medical innovation.

So I ask each of you to order four copies ($8 each) of Pharmocracy to send to your members of Congress. It is an important step in a multi-decade campaign to tear down the walls of bureaucracy that deny Americans access to more effective therapies at far lower prices.

FDA Admits ‘Crisis’: Life-saving Leukemia Drug Needed to Treat Children Could Disappear

As this article was being finalized, headline news stories reported that a crucial medicine to treat childhood leukemia is in such short supply that hospitals across the country may soon exhaust their supplies. The horrific result, according to the FDA and oncologists, is that hundreds and perhaps thousands of children are at risk of dying from a largely curable disease.

The FDA official in charge of the drug shortages program stated the situation is “dire…supplies are not meeting demand.”

The drug is methotrexate, which was first used in the 1950s. While it’s efficacy against solid tumors is mediocre, methotrexate has a high success rate when used to treat acute lymphoblastic leukemia, which most often strikes young children. This type of leukemia can quickly kill if not immediately treated.

There is a shortage of injectable preservative free methotrexate because a company making it voluntarily ceased production due to quality-control problems. The three other companies the FDA “allows” to make it have not yet stepped up to the plate to increase production.

FDA is seeking a foreign supplier to provide “emergency imports,” something the FDA has long claimed is unsafe for Americans to do on their own.

If it were not for burdensome regulations pertaining to generic drug manufacturing, there would be no shortage of methotrexate, prices would be far lower, and quality higher as companies could not rely on bureaucrats protecting them from free market competition.

Just imagine how bad the quality of automobiles would be if the government erected barriers that severely limited competition?

Stay Healthy So You Don’t Need Drugs

Americans needlessly suffer and die because of today’s suffocating regulatory quagmire.

The best way to avoid becoming a victim of artificial drug shortages is to stay free of disease. Life Extension members should take comfort in knowing that the many steps they take to retain their youthful health dramatically reduces their odds of contracting serious illness.

For longer life,

For Longer Life

William Faloon


1. ASHP Expert Panel on Drug Product Shortages, Fox ER, Birt A, et al. ASHP guidelines on managing drug product shortages in hospitals and health systems. Am J Health Syst Pharm. 2009 Aug 1;66(15):1399-406.

2. Rievman D. In this country, the elderly are forced to pay the world’s highest drug prices. Life Extension Magazine®. 2000 Jul;6(7).

3. Faloon W. Are we to become serfs of the drug monopoly? Life Extension Magazine®. 2000 Feb;6(2).

4. Faloon W. Consumer rape. Life Extension Magazine®. 2002 Apr;8(4).

5. Faloon W. The FDA versus the American consumer. Life Extension Magazine®. 2002 Oct;8(10).

6. Life Extension achieves “impossible” victory in the US House of Representatives. Life Extension Magazine®. 2003 Oct;9(10).

7. Faloon W. The $50.00 toll bridge. Life Extension Magazine®. 2004 Apr; 10(4):9-15.

8. Faloon W. The generic drug rip-off. Life Extension Magazine®. 2009 Aug; 15(8);7-13.

9. Available at: Accessed December 21, 2011.

10. Available at: Accessed December 21, 2011.

11. Available at: Accessed December 21, 2011.

12. Available at: Accessed December 21, 2011.

13. Available at: Accessed December 21, 2011.

14. Available at: Accessed December 21, 2011.

15. Available at: Accessed December 21, 2011.

16. Raju N, Sobieraj-Teague M, Hirsh J, O’Donnell M, Eikelboom J. Effect of aspirin on mortality in the primary prevention of cardiovascular disease. Am J Med. 2011 Jul;124(7):621-9.

17. Eidelman RS, Hebert PR, Weisman SM, Hennekens CH. An update on aspirin in the primary prevention of cardiovascular disease. Arch Intern Med. 2003 Sep 22;163(17):2006-10.

18. Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet. 2011 Jan 1;377(9759):31-41. Epub 2010 Dec 6. 18.

19. Mitka M. FDA, US hospital and pharmacy groups report drug shortages a growing problem. JAMA. 2011 Sep 14;306(10):1069-70.

20. Kaakeh R, Sweet BV, Reilly C, et al. Impact of drug shortages on US health systems. Am J Health Syst Pharm. 2011 Oct 1;68(19):1811-9.

21. Kent S. Victory over the FDA. Life Extension Magazine®. 1996 Sept;2(9).

22. Available at: Accessed December 22, 2011.

23. Chabner BA. Drug shortages--a critical challenge for the generic-drug market. N Engl J Med. 2011 Dec 8;365(23): 2147-9.

24. Available at: Accessed December 22, 2011.